Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial US$ 24.82 ★★★★★ 4.1 (18 reviews)
CagriSema Reduces Blood Pressure in Adults With Overweight or Obesity: REDEFINE 1 US$ 27.60 ★★★★★ 4.6 (24 reviews)
Cagrilintide–semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study US$ 26.83 ★★★★★ 4.8 (24 reviews)
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit US$ 22.40 ★★★★★ 4.5 (15 reviews)
Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study US$ 22.31 ★★★★★ 4.2 (18 reviews)
A new drug combo of semaglutide (GLP-1 receptor agonist) with cagrilintide (amylin analogue) failed to do as well as tirzepatide (GLP-1/GIP receptor agonist). The future of these medicines is hitting different receptors US$ 20.33 ★★★★★ 4.8 (8 reviews)
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial US$ 24.86 ★★★★★ 4.8 (8 reviews)
New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) Cagrilintide– Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) US$ 27.10 ★★★★★ 4.3 (12 reviews)
NEW: An analysis of patient-reported outcomes from the SURPASS-SWITCH trial found that adults with #Type2Diabetes who switched from dulaglutide to #tirzepatide not only saw stronger improvements in blood sugar and weight but US$ 29.09 ★★★★★ 4.0 (5 reviews)
REDEFINE 1 Trial Finds Cagrilintide–Semaglutide Combo Delivers Over 20% Weight Loss in Majority of Patients US$ 28.07 ★★★★★ 4.4 (5 reviews)
Three new phase 3 REIMAGINE studies provide some of the strongest evidence yet for CagriSema® (cagrilintide + semaglutide) in type 2 diabetes. 🔹 REIMAGINE 1 Studied people with early type 2 diabetes US$ 20.11 ★★★★★ 4.5 (22 reviews)
Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in the Management of Overweight and Obesity: A Network Meta‐Analysis of Randomized Clinical Trials - Hamarsheh - 2026 - Endocrinology, Diabetes & Metabolism US$ 20.45 ★★★★★ 4.2 (29 reviews)
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised US$ 21.94 ★★★★★ 5.0 (17 reviews)
GHK-Cu Peptides Before and After: Dosage, Benefits & How It Works for Skin and Hair US$ 22.63 ★★★★★ 4.6 (7 reviews)
Reducing Redness & Inflammation with GHK-Cu Copper Peptides – Vitali Skincare US$ 22.25 ★★★★★ 4.8 (26 reviews)
The Vitamin Shoppe Reduced Glutathione Antioxidant 250 (100 Capsules) (100 Capsules) : Health & Household US$ 22.79 Min. order: 1 piece ★★★★★ 4.4 (24 reviews) Sold : Login>>
Vitamin IVs, NAD+ & Peptides in White Plains – Infinite You US$ 22.66 Min. order: 1 piece ★★★★★ 4.1 (30 reviews) Sold : Login>>
NAD with Glutathione: Powerful Duo for Detox, Energy, and Anti-Aging US$ 20.03 Min. order: 1 piece ★★★★★ 4.8 (16 reviews) Sold : Login>>
Glutathione for Skin: How It Supports Radiance & Even Tone (2026) – HealthyHey US$ 23.16 Min. order: 1 piece ★★★★★ 4.6 (13 reviews) Sold : Login>>
